106332

CellPrime^® R³ IGF-I human

• Synonym(e): CellPrime^® R³ IGF-I human
• Empirische Formel (Hill-System): C₄₀₀H₆₁₉N₁₁₁O₁₁₅S₉
• CAS-Nummer: 143045-27-6
• Molekulargewicht: 9111.45

Eigenschaften

• Form: liquid
• Qualitätsniveau: 500
• Anwendung(en): pharma/biopharma processes; pharmaceutical
• Lagertemp.: 2-8°C

Beschreibung

Allgemeine Beschreibung

CellPrime^® rLR3 IGF is a is a non-animal origin (NAO) recombinant equivalent Insulin-like growth factor expressed in E.coli. CellPrime^® rLR3 IGF has a 13 amino acid N-terminal extension and position 3 substitution of Glutamic acid to Arginine contributes to increased stability and robustness in media formulations.

Anwendung

CellPrime^® rLR3 IGF is used to optimize cell culture formulations to increase cell proliferation, productivity, and viability. With an exact match for the Type I IGF receptor and a lower affinity for IGF binding proteins, CellPrime^® rLR3 IGF has increased effectiveness in serum-free cell culture media. Concentrations required to enhance performance is unique to each cell line and may be optimized by using in combination with CellPrime^® rInsulin.

Verpackung

106332.0005 / 5 ML /
106332.0100 / 100 ML /
106332.0250 / 250 ML /
106332.0500 / 500 ML /
106332.1000 / 1000 ML /

Rechtliche Hinweise

CellPrime is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Lagerklassenschlüssel: 10 - Combustible liquids
• WGK: WGK 3